Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause

American Journal of Primatology

Volumn 71, Issue 9, 2009, Pages 794-801

  Voytko, Mary Lou ^a   Tinkler, Gregory Paul ^a   Browne, Carole ^b   Tobin, Joseph R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

Author keywords

Hormones; Memory; Menopause; Monkeys; Neurobiology

Indexed keywords

ESTROGEN; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER RECEPTOR;

COGNITION; DISEASE TREATMENT; ESTROGENIC COMPOUND; HORMONE; MEMORY; NERVOUS SYSTEM; PRIMATE; REPRODUCTIVE CYCLE;

AGE; ANIMAL; ANIMAL MODEL; BRAIN; COGNITION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; METABOLISM; PATHOLOGY; REVIEW; STATISTICS; SYNAPSE;

AGE FACTORS; ANIMALS; BRAIN; COGNITION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MODELS, ANIMAL; NEUROPROTECTIVE AGENTS; RECEPTORS, NEUROTRANSMITTER; SYNAPSES;

EID: 69349093565     PISSN: 02752565     EISSN: 10982345     Source Type: Journal    
DOI: 10.1002/ajp.20705     Document Type: Review

References (110)

1. Adams MR, Kaplan JR, Manuck SB, Kroritnik DR, Parks JS, Wolfe MS, Clarkson TB. 1990. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 10:1051-1057.
2. Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L. 2006. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging 27:141-149.
3. Ancelin ML, Ritchie K. 2005. Lifelong endocrine fluctuations and related cognitive disorders. Curr Pharm Des 11: 4229-4252.
4. Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C, PERF Study Group. 2005. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12:12-17.
5. Behl C. 2002. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433-442.
6. Bethea CL, Reddy AP. 2008. Effect of ovarian hormones on survival genes in laser captured serotonin neurons from macaques. J Neurochem 105:1129-1143.
7. Bethea CL, Lu NZ, Gundlah C, Streicher JM. 2002. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23:41-100.
8. Binder EF, Schechtman KB, Birge SJ, Williams DB, Kohrt WM. 2001. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38: 137-146.
9. Browne C, Tobin JR, Voytko ML. 2009. Effects of two years of conjugated equine estrogens on cholinergic neurons in young and middle-aged ovariectomized monkeys. Br Res 1264:13-23.
10. Chen S, Nilsen J, Brinton RD. 2006. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 147:5303-5313.
11. Choi JM, Romeo RD, Brake WG, Bethea CL, Rosenwak Z, McEwen BS. 2003. Estradiol increases pre- and postsynaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta). Endocrinology 144:4734-4738.
12. Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. 2002. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry 17:610-618
13. Craig MC, Cutter WJ, Wickham H, van Amelsvoort TA, Rymer J, Whitehead M, Murphy DG. 2004. Effect of longterm estrogen therapy on dopaminergic responsivity in postmenopausal women-a preliminary study. Psychoneuroendocrinology 29:1309-1316.
14. Daniel JM. 2006. Effects of oestrogen on cognition: what have we learned from basic research? J Neuroendocrinol 18:787-795.
15. Davidson MC, Cutrell EB, Marrocco R. 1999. Scopolamine slows the orienting of attention in primates to cued visual targets. Psychopharmacology 142:1-8.
16. Di Paolo T. 1994. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5:27-41.
17. Disshon KA, Boja JW, Dluzen DE. 1998. Inhibition of striatal dopamine transporter activity by 17beta-estradiol. Eur J Pharmacol 345:207-211.
18. Dohanich GP, Witcher JA, Weaver DR, Clemens LG. 1982. Alteration of muscarinic binding in specific brain areas following estrogen treatment. Brain Res 241:347-350.
19. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. 1998. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253-1258.
20. Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. 2006. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology 31:2065-2078.
21. Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. 2008. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav 53:159-169.
22. Eberling JL, Wu C, Haan MN, Mungas D, Buonocore M, Jagust WJ. 2003. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging 24:725-732.
23. Erickson KI, Colcombe SJ, Raz N, Korol DL, Scalf P, Webb A, Cohen NJ, McAuley E, Kramer AF. 2005. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging 26:1205-1213.
24. Erickson KI, Colcombe SJ, Elavsky S, McAuley E, Korol DL, Scalf PE, Kramer AF. 2007. Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging 28:179-185.
25. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J, Women's Health Initiative Memory Study. 2004. Conjugated equine estrogens and global cognitive function in postmenopausal women: women's Health Initiative Memory Study. J Am Med Assoc 291:2959-2968.
26. Gardiner SA, Morrison MF, Mozley PD, Mozley LH, Brensinger C, Bilker W, Newberg A, Battistini M. 2004. Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Geriatr Psychiatry 12:621-630.
27. Genazzani AR, Pluchino N, Luisi S, Luisi M. 2007. Estrogen, cognition and female ageing. Hum Reprod Update 13:175-187.
28. Ghidoni R, Boccardi M, Benussi L, Testa C, Villa A, Pievani M, Gigola L, Sabattoli F, Barbiero L, Frisoni GB, Binetti G.2006. Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. Maturitas 54: 222-228.
29. Gibbs RB. 2000. Oestrogen and the cholinergic hypothesis: implications for oestrogen replacement therapy in postmenopausal women. Novartis Found Symp 230:94-111.
30. Gibbs RB, Gabor R. 2003. Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 74:637-643.
31. Gibbs RB, Nelson D, Anthony MS, Clarkson TB. 2002. Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologus monkeys. Neuroscience 113:907-914.
32. Gibbs RB, Edwards D, Lazar N, Nelson D, Talameh J. 2006. Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, cynomologous monkeys. J Neuroendocrinol 18:643-654.
33. Gibson CL, Gray LJ, Bath PM, Murphy SP. 2008. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131:318-328.
34. Gilardi KVK, Shideler SE, Valverde CR, Roberts JA, Lasley BL. 1997. Characterization of the onset of menopause in the rhesus macaque. Biol Reprod 57:335-340.
35. Goodman AL, Descalzi CD, Johnson DK, Hodgen GD. 1977. Composite pattern of circulating LH, FSH, estradiol, and progesterone during the menstrual cycle in cynomolgus monkeys. Proc Soc Exp Biol Med 155:479-481.
36. Green PS, Simpkins JW. 2000. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18:347-358.
37. Ha DM, Xu J, Janowsky JS. 2007. Preliminary evidence that long-term estrogen use reduces white matter loss in aging. Neurobiol Aging 28:1936-1940.
38. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. 1995. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37:434-441.
39. Hao J, Janssen WG, Tang Y, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH. 2003. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol 465:540-550.
40. Hao J, Rapp PR, Leffler AE, Leffler SR, Janssen WG, Lou W, McKay H, Roberts JA, Wearne SL, Hof PR, Morrison JH. 2006. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci 26:2571-2578.
41. Hao J, Rapp PR, Janssen WG, Lou W, Lasley BL, Hof PR, Morrison JH. 2007. Interactive effects of age and estrogen on cognition and pyramidal neurons in monkey prefrontal cortex. Proc Natl Acad Sci USA 104:11465-11470.
42. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA, MIRAGE Study Group. 2005. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 76:103-105.
43. Horvath KM, Hårtig W, Van der Veen R, Keijser JN, Mulder J, Ziegert M, Van der Zee EA, Harkany T, Luiten PG. 2002. 17beta-estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis. Neuroscience 110:489-504.
44. Hruska RE, Nowak MW. 1988. Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum. Brain Res 442:349-350.
45. Janowsky SJ, Chavez B, Orwoll F. 2000. Sex steroids modify working memory. J Cogn Neurosci 12:407-414.
46. Jayo MJ, Register TC, Carlson CS. 1998. Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys. Bone 23:361-366.
47. Jerome CP, Carlson CS, Register TC, Bain FT, Jayo MJ, Weaver DS, Adams MR. 1994. Bone functional changes in intact, ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry. J Bone Miner Res 9:527-540.
48. Jewitt DA, Dukelow WR. 1972. Cyclicity and gestation length of Macaca fascicularis. Primates 13:327-330.
49. Johnson RL, Kapsalis E. 1995. Ageing, infecundity, and reproductive senescence in free-ranging female rhesus monkeys. J Reprod Fertil 105:271-278.
50. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E. 1997. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521.
51. Kipp M, Karakaya S, Pawlak J, Araujo-Wright G, Arnold S, Beyer C. 2006. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors. Front Neuroendocrinol 27:376-390.
52. Kompoliti K, Chu Y, Polish A, Roberts J, McKay H, Mufson EJ, Leurgans S, Morrison JH, Kordower JH. 2004. Effects of estrogen replacement therapy on cholinergic basal forebrain neurons and cortical cholinergic innervation in young and aged ovariectomized rhesus monkeys. J Comp Neurol 472:193-207.
53. Kritzer MF, Kohama SG. 1998. Ovarian hormones influence the morphology, distribution, and density of tyrosine hydroxylase immunoreactive axons in the dorsolateral prefrontal cortex of adult rhesus monkeys. J Comp Neurol 395:1-17.
54. Kritzer MF, Kohama SG. 1999. Ovarian hormones differentially influence immunoreactivity for dopamine beta- hydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys. J Comp Neurol 409:438-451.
55. Kritzer MF, Adler A, Bethea CL. 2003. Ovarian hormone influences on the density of immunoreactivity for tyrosine hydroxylase and serotonin in the primate corpus striatum. Neuroscience 122:757-772.
56. Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, Staley JK, Garg PK, Seibyl JP, Innis RB. 2003. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160:1522-1524.
57. Lacreuse A, Herndon JG. 2003. Estradiol selectively affects processing of conspecifics' faces in female rhesus monkeys. Psychoneuroendocrinology 28:885-905.
58. Lacreuse A, Wilson ME, Herndon JG. 2002. Estradiol, but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. Neurobiol Aging 23:589-600.
59. LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS. 2007. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 14:191-202.
60. Lee SH, Mouradian MM. 1999. Up-regulation of D1A dopamine receptor gene transcription by estrogen. Mol Cell Endocrinol 156:151-157.
61. Leranth C, Roth RH, Elsworth JD, Naftolin F, Horvath TL, Redmond DE. 2000. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci 20:8604-8609.
62. Leranth C, Shanabrough M, Redmond DE. 2002. Gonadal hormones are responsible for maintaining the integrity of spine synapses in the CA1 hippocampal subfield of female nonhuman primates. J Comp Neurol 447:34-42.
63. Lord C, Buss C, Lupien SJ, Pruessner JC. 2008. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging 29:95-101.
64. Lu NZ, Bethea CL. 2002. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27:12-24.
65. Lu NZ, Eshleman AJ, Janowsky A, Bethea CL. 2003. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution and function in female macaques. Mol Psychiatry 8:353-360.
66. Maki PM. 2006. Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 138: 1027-1030.
67. Maki PM, Resnick SM. 2000. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21:373-383.
68. McCollough LD, Hurn PD. 2003. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 14:228-235.
69. Morissette M, Lévesque D, Di Paolo T. 1992. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study. Mol Pharmacol 42:480-488.
70. Morissette M, Sweidi SA, Callier S, Di Paolo T. 2008. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 290:60-99.
71. Moses-Kolko EL, Berga SL, Greer PJ, Smith G, Cidis Meltzer C, Drevets WC. 2003. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil Steril 80: 554-559.
72. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. 2000. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Coopera- tive Study. J Am Med Assoc 283:1007-1015.
73. Norbury R, Travis MJ, Erlandsson K, Waddington W, Ell PJ, Murphy DG. 2007. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study. Horm Behav 51:249-257.
74. Olson KL, Edwards E, Schechter N, Whalen RE. 1988. Muscarinic receptors in preoptic area and hypothalamus: effects of cyclicity, sex and estrogen treatment. Brain Res 448:223-229.
75. Paradiso K, Zhang J, Steinbach JH. 2001. The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid. J Neurosci 21:6561-6568.
76. Phillips SM, Sherwin BB. 1992. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485-495.
77. Rabbani O, Panickar KS, Rajakumar G, King MA, Bodor N, Meyer EM, Simpkins JW. 1997. 17 beta-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum. Exp Neurol 146:179-186.
78. Rainbow TC, Degroff V, Luine VN, McEwen BS. 1980. Estradiol 17 beta increases the number of muscarinic receptors in hypothalamic nuclei. Brain Res 198:239-243.
79. Rapp PR, Morrison JH, Roberts JA. 2003a. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 23:5708-5714.
80. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D, WHIMS Investigators. 2003b. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J Am Med Assoc 289:2663-2672.
81. Raz N, Rodrigue KM, Kennedy KM, Acker JD. 2004. Hormone replacement therapy and age-related brain shrinkage: regional effects. Neuroreport 15:2531-2534.
82. Schiff R, Bulpitt CJ, Wesnes KA, Rajkumar C. 2005. Shortterm transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomized placebo controlled pilot cross-over study. Psychoneuroendocrinology 30:309-315.
83. Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Offenbacher H, Eber B, Schumacher M, Freidl W. 1996. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc 44: 1307-1313.
84. Sherwin BB. 1988. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345-357.
85. Sherwin BB. 2003. Estrogen and cognitive functioning in women. Endocr Rev 24:133-151.
86. Sherwin BB. 2005. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us? Ann NY Acad Sci 1052:3-10.
87. Sherwin BB, Henry JF. 2008. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 29:88-113.
88. Sherwin BB, Phillips S. 1990. Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592:474-475.
89. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J Am Med Assoc 289:2651-2662.
90. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. J Am Med Assoc 291:2947-2958.
91. Smith YR, Giordani B, Lajiness-O'Neill R, Zubieta JK. 2001. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil Steril 76:1101-1107.
92. Steger RW, Peluso JJ. 1987. Sex hormones in the aging female. Endocrinol Metab Clin 16:1027-1043.
93. Stein DG. 2008. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 57:386-397.
94. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM. 2007. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA 104:6013-6018.
95. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. 1996. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432
96. Tang Y, Janssen WG, Hao J, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH. 2004. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex 14:215-223.
97. Tinkler GP, Tobin JR, Voytko ML. 2003. Dopaminergic neurons in the ventral tegmental area of intact and surgically menopausal monkeys. Soc Neuroscience Abstr Program No. 843.17.
98. Tinkler GP, Tobin JR, Voytko ML. 2004a. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol 469:507-521.
99. Tinkler GP, Tobin JR, Voytko ML. 2004b. Dopaminergic fibers in the prefrontal cortex following two years of estrogen loss or replacement in young adult surgically menopausal monkeys. Soc Neurosci Abstr Program No. 72.10
100. Tokuyama Y, Reddy AP, Bethea CL. 2008. Neuroprotective actions of ovarian hormones without insult in the raphe region of rhesus macaques. Neuroscience 154:720-731.
101. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. 2005. Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol 192:387-393.
102. Voytko ML. 2000. The effects of long-term ovariectomy and estrogen replacement therapy on learning and memory in monkeys. Behav Neurosci 114:1078-1087.
103. Voytko ML. 2002. Estrogen and the cholinergic system modulate visuospatial attention in monkeys. Behav Neurosci 116:187-197.
104. Voytko ML, Higgs CJ, Murray R. 2008. Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys. Neuroscience 154:1205-1217.
105. Williams PN, Tinkler GP, Tobin JR, Voytko ML. 2004.Cholinergic fiber density in area 46 of the prefrontal cortex of middle-aged surgically menopausal monkeys. Soc Neurosci Abstr 30, Program No. 72.2.
106. Wise PM. 2006. Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 138:831-835.
107. Wise PM, Dubal DB, Rau SW, Brown CM, Suzuki S. 2005. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative. Endocr Rev 26:308-312.
108. Wolf OT, Heinrich AB, Hanstein B, Kirschbaum C. 2005. Estradiol or estradiol/progesterone treatment in older women: no strong effects on cognition. Neurobiol Aging 26:1029-1033.
109. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC. 2002. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. J Am Med Assoc 288:2123-2129.
110. Zec RF, Trivedi MA. 2002. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev 12:65-109.